Matthew Navarro is the founder of Glympse Bio. Glympse Bio has raised $69M in total funding. Latest round: Series B. Based in Cambridge, USA.
Matthew T. Navarro, J.D., was appointed Chief Financial Officer of Glympse Bio in July 2021. He oversees the company's financial strategy and operations. Navarro has an extensive background in the biopharma industry, including advising companies on strategic and financial matters and working at Pfizer Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library